Literature DB >> 17019272

Therapeutic drug monitoring.

Gillian M Shenfield1, Raymond G Morris.   

Abstract

PURPOSE OF REVIEW: Traditionally, therapeutic drug monitoring has been used for the management of epilepsy, cardiac arrhythmias, asthma and depression. This review provides an update, particularly for the newer clinical applications, and how therapeutic drug monitoring (including use of analytical and interpretation tools) can improve clinical outcomes. RECENT
FINDINGS: Improved drug assay methodologies and a greater understanding of pharmacokinetic and pharmacodynamic mechanisms has allowed the use of therapeutic drug monitoring for immunosuppressant drugs in organ transplant recipients, antiretroviral agents for HIV/AIDS and antimetabolite drugs for leukaemia. In addition, new computer software to analyse drug concentrations in complex populations is being developed and introduced into routine clinical applications to allow increasingly patient-specific assay interpretation.
SUMMARY: Therapeutic drug monitoring assists in improving clinical success rates and minimizing toxicity. The use of therapeutic drug monitoring is therefore likely to become more widespread as new modalities are adopted.

Entities:  

Year:  2002        PMID: 17019272     DOI: 10.1097/00001503-200212000-00014

Source DB:  PubMed          Journal:  Curr Opin Anaesthesiol        ISSN: 0952-7907            Impact factor:   2.706


  1 in total

Review 1.  Dried Blood Spot Technique Applied in Therapeutic Drug Monitoring of Anticancer Drugs: a Review on Conversion Methods to Correlate Plasma and Dried Blood Spot Concentrations.

Authors:  Valentina Iacuzzi; Bianca Posocco; Martina Zanchetta; Sara Gagno; Ariana Soledad Poetto; Michela Guardascione; Giuseppe Toffoli
Journal:  Pharm Res       Date:  2021-04-12       Impact factor: 4.200

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.